SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,191.76 549.28
(1.06%)

Dow Jones

7,764.37 24.43
(0.32%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,840.19 115.33
(1.08%)

Forex

USD-INR

95.08 -0.14
(-0.15%)

EUR-INR

106.23 -0.27
(-0.26%)

GBP-INR

125.74 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540694

INE236W01016

47.3676118

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

47.22

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	91.60	89.91	131.37	207.01	348.67	154.28
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	91.60	89.91	131.37	207.01	348.67	154.28
Other Income	0.73	2.44	0.84	9.84	0.95	0.75
Stock Adjustments	-3.21	3.39	6.74	4.22	4.47	4.30
Total Income	89.12	95.74	138.95	221.07	354.09	159.33
EXPENDITURE :
Raw Materials	55.08	63.98	93.93	151.12	234.49	108.26
Power & Fuel Cost	3.67	3.25	3.61	5.99	5.68	4.88
Employee Cost	14.35	14.45	15.90	20.27	18.32	14.35
Other Manufacturing Expenses	1.43	1.36	0.91	1.85	2.96	1.60
Selling & Administrative Expenses	5.93	10.63	13.04	18.21	23.49	13.56
Miscellaneous Expenses	1.02	1.10	2.89	2.12	2.65	0.59
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	81.49	94.77	130.28	199.56	287.60	143.24
Operating Profit	7.63	0.97	8.66	21.51	66.49	16.08
Interest	6.74	7.64	9.77	10.92	8.31	3.98
Gross Profit	0.89	-6.67	-1.11	10.59	58.18	12.10
Depreciation	6.08	6.27	7.75	8.52	5.12	2.24
Profit Before Tax	-5.19	-12.94	-8.86	2.07	53.06	9.86
Tax	0.00	0.00	0.00	2.11	13.47	3.18
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.46	-2.59	-0.22	0.62	-0.11	-0.57
Reported Net Profit	-4.73	-10.34	-8.65	-0.66	39.71	7.25
Extraordinary Items	0.03	-0.45	-1.56	-0.27	0.00	0.00
Adjusted Net Profit	-4.76	-9.89	-7.09	-0.39	39.71	7.25
Adjustment below Net Profit	0.13	0.08	0.19	0.72	0.21	-0.70
P & L Balance brought forward	48.76	59.02	63.16	63.10	24.22	17.67
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	-4.33	0.00	1.04	0.00
P & L Balance carried down	44.17	48.76	59.02	63.16	63.10	24.22
Dividend	0.00	0.00	0.00	0.00	1.04	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	10.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	1.00	0.00
Earnings Per Share-Unit Curr	-3.62	-7.92	-6.62	-0.51	38.31	13.99
Earnings Per Share(Adj)-Unit Curr	-3.62	-7.92	-6.62	-0.51	30.65	5.60
Book Value-Unit Curr	47.37	50.88	58.74	61.91	76.00	76.99
Book Value(Adj)-Unit Curr	47.37	50.88	58.74	61.91	60.80	30.80

74,729.27 413.66 ( 0.56%)

52,191.76 549.28 (1.06%)

7,764.37 24.43 (0.32%)

65,489.63 1,063.68 (1.65%)

10,840.19 115.33 (1.08%)

95.08 -0.14 (-0.15%)

106.23 -0.27 (-0.26%)

125.74 -0.30 (-0.24%)

0.60 0.00 (-0.23%)